November 19, 2024
Endpoints News: J&J and Protagonist Announce Phase 3 Trial Results for icotrokinra (JNJ-2113, formerly PN-235)
calendar_today
November 25, 2024
domain
protagonist-therapeutics
Need help?
Contact usNovember 19, 2024